Article
The interleukin-10 promoter polymorphism rs1800872 (-592C>A), contributes to cancer susceptibility: meta-analysis of 16,785 cases and 19,713 controls.
PloS one - 1 Jan 2013
Ding Qi, Shi Ying, Fan Bo, Fan Zhijiang, Ding Li, Li Feng, Tu Wenjian, Jin Xiaohua, Wang Jing
Abstract excerpt
Interleukin-10 (IL-10) is a multifunctional cytokine which participates in the development and progression of various malignant tumors. To date, a number of case-control studies were conducted to detect the association between IL-10-592C>A polymorphism and cancer risk in humans. However, the results of these studies on the association remain conflicting. In an effort to solve this controversy, we performed a...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
